DNMT3B and breast carcinoma: SGI-1027, a DNMT inhibitor, causes selective degradation of DNMT3B in several human cancer cells, such as melanoma, lung carcinoma and breast cancer, but shows little or no cytotoxic effect on some types of cancer cells, such as hepatoma cells 43, 44.